DNase I footprinting of the rat TGFa promoter in the presence of crude cell nuclear extract revealed three sites of protein-DNA interaction (Fp-A, Fp-B, Fp-C) in the region from 7222 to +73. Mutation of speci®c sites within the Fp-A and Fp-B regions reduced expression of a TGFa promoter-reporter gene (TGFaLUC) from 50 ± 90% in transiently transfected CHO cells, indicating the importance of protein/DNA interactions at these sites. Since Fp-A contained a perfect AP2 consensus sequence (5'-GCCNNNGGC-3') as its center, we investigated the possibility that AP2 binding is important for TGFa promoter activity. A double-stranded oligonucleotide spanning Fp-A displayed a distinct mobility shift in the presence of nuclear extract that was inhibited by an excess of known functional AP2-binding sequence. Moreover, a similar mobility shift occurred in the presence of puri®ed AP2 protein, and the further addition of AP2 antibody produced a supershifted complex. More re®ned DNase I footprinting of a smaller, oligonucleotide probe in the presence of puri®ed AP2 protein revealed a protected region that included the putative AP2 binding site. Additionally, co-transfection of an AP2 expression vector increased TGFaLUC expression 25-fold in Drosophila Schneider cells. These various ®ndings corroborate a role for AP2 in TGFa promoter activity. The Fp-B region contains a T 5 motif that has been previously suggested to function as an atypical TATA box. An Fp-B oligonucleotide displayed a speci®c gel mobility shift in the presence of a TATA binding protein (TBP)-TFIIA complex, and the further addition of TBP antibody produced a supershift. These results con®rm that protein binding within Fp-B is functionally important, and they also indicate that the T 5 motif functions as a TBP binding site.
Introduction
Enhanced expression of the EGF receptor (EGF-R) ligand, transforming growth factor-alpha (TGFa) in neoplastic cells and tissues has been widely reported. Though broadly expressed in normal developing and adult tissues (reviewed in Lee et al., 1995) , the levels of TGFa mRNA and protein are often increased in cells transformed by chemical carcinogens (Liu et al., 1988; Luetteke et al., 1988; Lee et al., 1991) , retroviruses (Twardzik et al., 1982 (Twardzik et al., , 1983 , and activated cellular oncogenes including Ras (Salomon et al., 1987; Ciardiello et al., 1988 Ciardiello et al., , 1990 Godwin and Lieberman, 1990) . Additionally, a variety of solid tumors contain increased levels of TGFa protein and/or mRNA compared to the corresponding normal tissues (reviewed in Lee et al., 1995) . Underscoring the potential importance of these inductions, overexpression of TGFa transforms some normal, EGF receptorpositive cells in culture (Rosenthal et al., 1986) , and promotes hyperplastic growth (Sandgren et al., 1990; Jhappan et al., 1990) , markedly accelerates oncogeneinduced tumorigenesis (Sandgren et al., 1993; Murakami et al., 1993) , and directly induces the formation of mammary adenocarcinomas in vivo (Matsui et al., 1990; Sandgren et al., 1995) . These observations emphasize the importance of identifying mechanisms that deregulate TGFa expression during neoplastic progression.
We recently investigated the induction of TGFa that accompanies epithelial cell transformation. We found that TGFa mRNA was induced 25-to 50-fold in rat liver epithelial cell (RLEC) clones transformed either by exposure to chemical carcinogen or introduction of an activated Ha-ras gene (Berkowitz et al., 1996a) . Though primarily due to increased transcription, TGFa mRNA was also consistently stabilized. Regulation of TGFa expression at both transcriptional and post-transcriptional levels has been described by others, albeit for non-matched cell lines (Coey et al., 1992) . The methylation status of the TGFa promoter in the transformed RLECs was not consistently altered, but several DNase I hypersensitive sites were identi®ed in distant 5'¯anking sequence that correlated with transformation-or TPA-mediated inductions of TGFa gene expression (Berkowitz et al., 1996a) .
The TGFa promoter is G+C-rich and lacks obvious TATA and CAAT motifs (Blasband et al., 1990; Jakobovits et al., 1988) . Transcription from the rat promoter initiates at two major and multiple minor sites spanning 200 bp of DNA (Blasband et al., 1990) , while the human promoter reportedly contains a single initiation site (Jakobovits et al., 1988) . Using an in vivo footprinting assay, we previously observed evidence of protein-DNA interactions at Sp1-like sites within the promoter region in transformed RLECs (Chen et al., 1994) . We also showed that Sp1 bound these same sites in vitro, that selective mutation of Sp1 binding sites dierentially inhibited transcription from the two predominant start sites, and that co-expression of Sp1 was essential for TGFa promoter activity in transfected Drosophila Schneider cells (Chen et al., 1992) . Though Sp1 protein and activity levels were comparable in normal and transformed RLECs, in vivo footprinting showed that Sp1 was not bound to the promoter in a normal RLEC line that contained virtually undetectable levels of TGFa mRNA (Chen et al., 1994) . These results are consistent with a report from another laboratory that 5-azacytidine induced TGFa gene transcription by enhancing Sp1 binding through an unknown mechanism(s) (Shin et al., 1992) .
In this report, we extend our analyses of the TGFa promoter. Through combined in vitro footprinting, gelmobility shift and functional assays, we demonstrate a role for AP2, a transcription factor that has been implicated as an eector of both N-ras (Kannan et al., 1994) and protein kinase C (Imagawa et al., 1987) , and a key modulator of epithelial cell dierentiation (Luscher et al., 1989; Mitchell et al., 1991) . In addition, we extend a previous report that TBP recognizes a T 5 motif in the TGFa promoter, and provide evidence that this interaction is functionally important.
Results

Footprinted regions of the TGFa promoter are functionally important
We previously showed that the rat TGFa promoter directs transcription in vitro in the presence of crude HeLa cell nuclear extract (Chen et al., 1992) . As part of those studies, we also showed (but did not report) that in the presence of HeLa cell nuclear extract, DNase I footprinting revealed three sites of DNAprotein interaction (Fp-A, Fp-B, Fp-C) within the promoter region from 7222 to +73 (Figure 1a ). The location of these footprinted regions with respect to the two predominant transcription initiation sites is shown in Figure 1b . Footprint C likely corresponds to a region of the human promoter previously shown to bind a 105 kDa activity termed TIBP-1 (Shin and Kudlow, 1994) ; it was not further investigated.
To assess the functional importance of protein binding within footprints A and B, wild-type sequence was independently replaced with EcoRI linkers at three separate sites within Fp-A, and two sites within Fp-B (Table 1) . The resulting promoter mutants were compared with wild-type sequence for their ability to direct expression of a coupled luciferase reporter gene in transiently transfected CHO cells (Figure 2) . In contrast to the wild-type promoter, which directed high levels of luciferase activity (102 257+3486 light units (LU)/mg protein), promoter constructs harboring mutations within Fp-A (LS-1, LS-2, LS-3) or Fp-B (LS-4, LS-5) yielded markedly less activity. Mutations within Fp-A produced the greatest eect, with the luciferase activity of LS-3 reduced by 490%. This degree of inhibition was similar to that observed with LS-6, which harbored a mutation in a previously implicated Sp1 site (7112/7100) (Chen et al., 1992) . Nevertheless, mutations within Fp-B (LS-4 and LS-5) also aected promoter activity, inhibiting luciferase expression by 50 ± 70%. In contrast, LS-7 and LS-8, which harbored EcoRI mutations in non-footprinted regions with no homology to known transcription factor binding sites, directed levels of luciferase activity comparable to that of the wild-type promoter. These results indicate that the nucleotide sequences protected by protein binding in footprints A and B are functionally important for TGFa promoter activity.
Transcription factor AP2 binds to Fp-A
We utilized the electrophoretic mobility shift assay (EMSA) to identify proteins that bind to sequences in footprint A. Figure 3a shows that a predominant shifted complex (arrow) was formed when 32 P-labeled Fp-A probe was incubated with CHO nuclear extract. This DNA-protein interaction was speci®c since its formation was competitively inhibited in the presence of a 25-fold molar excess of unlabeled Fp-A DNA. This result is consistent with the footprinting and functional assays described above.
The Fp-A region (7187 to 7154) contains at its center, a DNA sequence element with perfect homology to the AP2 consensus binding site (5'-GCCNNNGGC-3'; see Figure 3c ). It also contains another motif that displays a 7 out of 8 match to the E2F concensus binding site (5'-TTT[C/G][C/G]CGC-3'), as well as a GC-rich stretch that could harbor binding sites for transcription factors Sp1, YY1, or Egr. To identify proteins present in CHO nuclear extracts that are responsible for the Fp-A gel-shift activity, we tested whether oligonucleotides corresponding to these and other consensus binding sites could competitively inhibit this DNA-protein interaction. Figure 3a demonstrates that a 25-fold molar excess of a bona ®de AP2 binding site oligonucleotide from the human metallothionein IIa (hMtIIa) promoter (Williams et al., 1988; Williams and Tjian, 1991) completely inhibited the Fp-A gel-shift, but an oligonucleotide harboring a mutated AP2 binding site (Williams et al., 1988) did not. In contrast, similar excesses of oligonucleotides corresponding to E2F, Sp1, TATA-binding protein (TBP), and AP1 binding sites had either no eect, or only modestly inhibited the Fp-A binding activity (Figure 3a) . Consensus YY1, Egr-1, and ets binding sequences were also without eect (data not shown).
AP2 binding to Fp-A was corroborated with three additional EMSAs. First, in a reversal of the experiment described above, we showed that a gelshift complex produced with radiolabeled AP2 consensus oligonucleotide and CHO nuclear extract was competitively inhibited by a 50-fold molar excess of Fp-A region oligonucleotide (Figure 3b, arrow) . Formation of the complex was also inhibited in the presence of a similar excess of unlabeled AP2 oligonucleotide, but not by the mutant AP2 sequence used above. Second, to better de®ne site(s) of protein interaction, we compared the ability of wild-type Fp-A sequence and a series of Fp-A oligonucleotides containing consecutive 7 ± 9 bp substitutions to competitively inhibit the AP2 consensus binding site gel-shift. Figure 3c shows that mutants containing substitutions in the 5' and 3' termini of Fp-A (Mt-1, Mt-4) retained the ability to competitively inhibit the AP2 gel-shift, but oligonucleotides harboring mutations in the AP2-like motif (Mt-3) or its immediate 5'¯anking sequence (Mt-2) were ineective competitors. Third, the binding of AP2 was de®nitively demonstrated through the use of puri®ed transcription factor and speci®c antibody. Incubation of puri®ed AP2 protein (Promega) with radiolabeled Fp-A probe produced a shifted protein-DNA complex that comigrated with the complex formed when Fp-A probe was incubated with CHO nuclear extract (Figure 3d ; arrow). Importantly, addition of AP2 antibody to Fp-A EMSAs supershifted complexes formed with either puri®ed AP2 protein or CHO nuclear extract (asterisk). Table 1 ). Constructs containing mutations in a critical Sp1 site (LS-6) and in non-critical promoter regions (LS-7 and LS-8) are included for comparison. Wt, wild-type 
As a ®nal con®rmation that AP2 binds to Fp-A, and to achieve better resolution of the protected region, we developed a modi®ed DNase I footprinting protocol. Rather than using a relatively large restriction fragment probe labeled via a Klenow enzymemediated ®ll-in reaction, we instead used a smaller 98 bp synthetic oligonucleotide with the AP2 binding site as its center. Since the upper strand's 5' end was labeled to a high speci®c activity (10 9 c.p.m./mg) before annealing it to the unlabeled complementary sequence, this allowed us to include less protein/nuclear extract in the DNase I footprinting reactions, thereby improving footprint de®nition. Incubation of this probe with puri®ed AP2 protein yielded a distinct DNase I footprint (Figure 4) . A size comparison of the DNase I-treated products with a set of dideoxy sequencing reactions generated with a primer whose 5' end corresponded to the 5' (labeled) end of the 98 bp probe con®rmed that the protected region included a portion of the AP2 binding site and corresponded approximately to the 5' half of the original Fp-A footprint (see Figure 1 ). An identical result was obtained using crude nuclear extract derived from a transformed rat liver epithelial cell line, GP6 ( Figure  4) . We utilized this cell line because it expresses the endogenous TGFa gene at high levels. As shown below ( Figure 6 ), GP6 nuclear extract produced an AP2-like gel-shift that was indistinguishable from that generated with CHO nuclear extract. Considering that only one strand was examined in the present study, these results are in close agreement with both the original footprint analysis and the EMSA ®ndings of Figure 3c .
AP2 activates the TGFa promoter in Drosophila Schneider cells
Since Drosophila Schneider cells lack functional homologues of some mammalian transcription factors, including AP2 (Perkins et al., 1988) , they are frequently used to test the functional importance of putative transcription factor binding sites. Thus, activation in these cells of a target promoter by an exogenously provided transcription factor is interpreted to con®rm a role for that factor. Hence, we used this approach to establish the functional relevance of AP2 binding. A TGFa promoter-luciferase gene (TGFa-LUC) was transiently transfected with the pPAC parental vector or the vector encoding AP2 under control of the insect-speci®c Drosophila actin 5C promoter (pPAC-AP2+). Figure 5 shows that when transfected with parental vector, TGFaLUC produced only 10+1 LU/mg lysate protein. However, cotransfection of the AP2 expression vector increased TGFaLUC activity 25-fold to 245+11 LU/mg lysate protein. In contrast, co-transfection of a vector containing the AP2 cDNA in the antisense orientation had no appreciable eect on TGFaLUC expression. Together with the analyses of AP2 site mutations shown in Figure 2 , these results provide strong evidence that transcription factor AP2 not only binds speci®cally to the TGFa promoter at Fp-A, but is also required for activation of the TGFa promoter.
AP2 activity levels are similar in normal and transformed RLECs
We recently showed that TGFa gene transcription was increased 5-to 10-fold in chemically transformed GP6 cells compared to their normal parental line, WB (Berkowitz et al., 1996a) . Here we utilized the EMSA to determine if induced transcription in GP6 cells is oligonucleotide from the human metallothionein-II a (hMtII a ) promoter was tested for EMSA activity with CHO cell nuclear extract as described in (a) except that a 50-fold molar excess of unlabeled competitor was added. An arrow denotes the migration of speci®c complex. (c) End-labeled, double-stranded Fp-A oligonucleotide was analysed as in (a) except that 3 mg of cell nuclear extract was Figure 1b) was incubated in the absence (7) or presence (+) of AP2 protein (30 ng) or crude nuclear extract (30 mg), treated with varying amounts of DNase I (0.05 ± 2.0 units), and the resulting reaction products resolved by PAGE. The region protected from DNase I cleavage in the presence of nuclear extract or AP2 protein is bracketed due to increases in the levels or activity of AP2. Figure  6 shows that WB and GP6 nuclear extracts both produced a shifted Fp-A complex with comparable mobility to that produced with CHO nuclear extract. Moreover, similar amounts of shifted complex were produced by two independent preparations each of WB and GP6 nuclear extracts. Hence, we conclude that activation of TGFa gene expression in GP6 cells is not accompanied by a general increase in AP2 binding activity.
TATA binding protein interacts with Fp-B
The TGFa promoter lacks TATA motifs (Jakobovits et al., 1988; Blasband et al., 1990; Berkowitz et al., 1996b) , but Shin and colleagues (1995) recently sugested that a stretch of T residues in a T 5 C 5 motif might function as an atypical TATA box. This motif is contained within a conserved 19 bp sequence located 23 or 24 nucleotides upstream of the predominant human and rat transcription start sites, respectively. Shin and coworkers showed that an oligonucleotide containing the T 5 motif and¯anking human promoter sequence displayed a speci®c mobility shift in the presence of TATA binding protein (TBP). Moreover, replacement of the T 5 motif with unrelated sequence (Figure 2) . Speci®cally, the LS-4 mutation, which replaced three of the ®ve T residues (Table 1) , reduced luciferase expression by 55%, while mutation of the 3' contiguous C 5 sequence (LS-5; Table 1 ) produced a slightly greater degree of inhibition (68%). We used the EMSA to further analyse Fp-B. As shown in Figure 7 , a 19 bp oligonucleotide corresponding to Fp-B displayed a speci®c mobility shift (arrow) when incubated in the presence of puri®ed TBP/TFIIA (kindly provided by R Roeder). Production of this complex was competitively inhibited in the presence of 50-fold molar excesses of unlabeled Fp-B or AdMLP TATA box oligonucleotides, while the addition of TBP antibody produced a supershifted complex (asterisk). Competition reactions performed with Fp-B oligonucleotides containing sequential 5 bp mutations showed that replacement of the T 5 motif with the sequence AGCAG diminished the ability of resulting oligonucleotides to inhibit the gel-shift activity. In contrast, substitutions in the¯anking sequences had relatively little eect (data not shown). Collectively, these results extend the ®ndings of Shin and colleagues, and are consistent with the T 5 sequence functioning as a TBP binding site.
Discussion
Our ®ndings reveal a role for the transcription factor AP2 in activation of the TGFa promoter. AP2 was originally isolated from HeLa cells as an activity that bound to regions of the SV40 and human metallothionein-IIa (hMtIIa) promoters (Lee et al., 1987; Mitchell et al., 1987) . It was subsequently shown to function as a homodimer, and to bind the consensus palindromic sequence, 5'-GCCNNNGGC-3' (Williams et al., 1988; Williams and Tjian, 1991) . Other known target genes include AP2 itself (Bauer et al., 1994) , cmyc and growth hormone (Imagawa et al., 1987) . A 437-amino-acid protein, AP2 includes a proline and glutamine-rich amino-terminal domain required for transactivation, and a helix-span-helix (HSH) region essential for DNA binding and homodimerization (Williams and Tjian, 1991) . Interestingly, alternative splicing of the AP2 gene in the human teratocarcinoma cell line, PA-1, produces a truncated protein, AP2-B (Buettner et al., 1993) . Due to the concomitant loss of the HSH region and dimerizing activity, AP2-B inhibits transactivation in a dominant negative fashion. Full-length AP2 appears to be an eector for at least two dierent signal transduction pathways, one involving phorbol ester and protein kinase C (PKC), the other mediated by cAMP-dependent protein kinase A (Imagawa et al., 1987) . It is believed to have a role in modulating the expression of neuraland epithelial-speci®c genes, and hence to be a key transcriptional regulator of embryonic morphogenesis and adult epithelial cell dierentiation (Mitchell et al., 1991) . This notion is partly supported by the recent demonstration that AP2 7/7 mice die at birth due to failure of cranial neural-tube closure and defects in cranial ganglia development (Schorle et al., 1996; Zhang et al., 1996) .
The ®nding that AP2 is required for optimal TGFa promoter activity is consistent with observations that TGFa expression is prominent in regions of the central nervous system, and in epithelioid tissues. It is also tempting to speculate that given its involvement in phorbol ester and PKC signaling, AP2 mediates observed inductions of TGFa gene transcription by TPA (Pittelkow et al., 1989; Mueller et al., 1989; Raymond et al., 1989; Berkowitz et al., 1996a) . We have been unable to test this hypothesis directly because it has not been possible to demonstrate TPA induction of TGFa promoter-reporter gene constructs in transfected cells. An explanation may lie in our recent identi®cation of a TPA-dependent hypersensitive site at 713 kb (Berkowitz et al., 1996a) , since the TPA responsiveness of constructs containing such extensive 5'¯anking sequence has not yet been tested. However, induction of TGFaLUC by serum was not impaired when the AP2 site (7164/ 7172) was mutated, even though the overall level of reporter gene activity was reduced (data not shown). Finally, it is interesting to note that AP2 is also required for maximal EGFR promoter activity (Johnson, 1996) , suggesting a possible mechanism whereby expression of these two functionally related genes could be coordinately regulated.
Our results further indicate that the TGFa promoter includes a functional TBP binding site. Many mammalian class II promoters contain a TATA-like sequence located 25 ± 30 bases upstream of the transcription start site. The binding of TBP to these sites serves to nucleate the ordered assembly of TBPassociated factors (TAFs), which are required for the formation of a stable initiation complex (Zhou et al., 1993; Martinez et al., 1994) . Studies of a diverse set of genes suggest that non-consensus sequences can function as TBP binding sites provided they arē anked by the proper sequence elements and located an appropriate distance 5' of the initiation site. Examples of TATA-less promoters that contain nonconsensus TBP binding sites include SV40 major late (Wiley et al., 1992) , terminal deoxynucleotidyltransferase (Martinez et al., 1994) , and dihydrofolate reductase (Wiley et al., 1992) . As noted, the TGFa promoter does not contain obvious TATA-like sequences. However, the present analysis indicates that a T 5 motif located in the center of FpB functions as a non-consensus TATA box and binds the TBP/TFIIA complex. Importantly, mutations within FpB that disrupt the T 5 element or the immediate¯anking sequence diminish expression from the TGFa promoter by 50 ± 70%. These results extend the ®ndings of Shin and coworkers (1995) , who observed that the corresponding, conserved sequence of the human TGFa promoter also displayed a gel-mobility shift in the presence of TBP.
Some TATA-less promoters have been shown to contain an initiator (Inr) element encompassing the transcription start site that in conjunction with bound, juxtaposed TBP, directs accurate transcriptional initiation (Martinez et al., 1994) . Consistent with this model, the TGFa promoter's predominant 759 transcription start site is contained within FpC, indicative of protein binding to this region. Moreover, the corresponding human TGFa promoter sequence binds a 105 kDa protein, and has been suggested to serve an Inr-like function (Shin and Kudlow, 1994) . These observations raise the possibility that interactions between TGRa's T 5 motif and TBP are stabilized through protein-protein interactions with Inr-binding protein(s), TFIIA, TAFs, and additional components of the transcriptional machinery, a scenario that has been proposed for other promoters (Roy et al., 1993; Zhou et al., 1992) . Given the essential role of Sp1 in TGFa promoter activity (Chen et al., 1992 (Chen et al., , 1994 Shin et al., 1992 ; see also Figure 2 ), it should also be noted that spatially precise binding of TBP and associated TAFs is required for Sp1-mediated activation of gene transcription (Pugh and Tjian, 1990; Smale et al., 1990; Zhou et al., 1993) .
Studies of the TGFa promoter have now established important roles for two transcription factors, Sp1 and AP2. Since the long term goal is to identify mechanisms underlying the activation of TGFa gene transcription in neoplastic cells, we compared Sp1 and AP2 activity levels in normal and transformed RLEC cells that express the TGFa gene at low and high levels, respectively. We found that Sp1 (Chen et al., 1994) and AP2 ( Figure 6 ) levels were indistinguishable in extracts from the normal and neoplastic counterparts. Hence, TGFa gene activation cannot be accounted for by changes in the levels or binding activities of these two critical factors, at least in this particular model. Alternate explanations are that modi®cation (e.g. phosphorylation) of either protein dierentially aects its activity toward the TGFa promoter, or that accessibility of these factors to TGFa promoter sequences is impaired in the normal RLECs. In fact, in vivo footprinting analysis revealed no evidence of protein interactions at Sp1 sites in the normal cell line with the lowest levels of TGFa mRNA (Chen et al., 1994) . The very high G+C content (480%) of the promoter region containing the AP2 site (7164/7172) has made in vivo footprinting analysis of this region problematic. Hence, modulation of AP2 or Sp1 accessibility remains a viable explanation. Finally, it is also possible that an as yet unidenti®ed transcription factor(s), plays a critical role in the transformationassociated induction of TGFa promoter activity. Future experiments will be aimed at testing these various possibilities.
Materials and methods
Cell lines, transient transfections, and luciferase assays
The CHO-K1 (American Type Culture Collection) and GP6 (kindly provided by J Grisham) cell lines were maintained in Minimal Essential Media (MEM) containing 0.1 M non-essential amino acids, 50 mg/ml gentamicin, and 5% fetal bovine serum (FBS). Schneider SL2 cells (American Type Culture Collection), an embryonic Drosophila cell line, were maintained in Schneider's Medium (Life Technologies), 10% FBS, 0.1 mM nonessential amino acids and 50 mg/ml gentamicin.
Plasmid DNAs derived from pGL2 basic (Promega) were introduced into CHO cells by lipid-mediated transfection using either Lipofectamine (Life Technologies) or Dosper (Boehringer Mannheim) reagents at ratios of 1 ± 1.5 mg plasmid DNA per 7 ± 10 ml lipid as speci®ed by the manufacturer. Drosophila Schneider SL2 cells were transfected by the calcium phosphate-DNA co-precipitation method (Graham and Van Der Eb, 1973 ) using a total of 3 mg of plasmid DNA (1.5 mg pTGFaLUC and 1.5 mg pPac vector) per dish. The parental expression vector, pPAC, and vectors containing sense (pPAC-AP2+) and antisense (pPAC-AP27) AP2 cDNAs downstream of the Drosophila actin 5C promoter were kindly provided by R Buettner.
For luciferase assays, cells were harvested in cold phosphate buered saline (PBS) (pH 7.4), pelleted at 1000 g, resuspended in lysis buer [100 mM potassium phosphate (pH 7.4), 1 mM dithiothreitol (DTT)], and subjected to three cyles of freeze-thawing. Cell debris were removed at 16 000 g (48C), and the protein content of clari®ed extracts determined using BioRad Reagent. Luciferase activity was measured via a AutoLumat LB953 luminometer ( 
Linker-scanning mutagenesis
To replace wild-type TGFa promoter sequence with EcoRI linkers, two independent PCR reactions were performed (see diagram below). Primers for one reaction were a universal 5' oligonucleotide containing an KpnI recognition sequence followed by TGFa promoter sequence, and a variable 3' mutant oligonucleotide containing the EcoRI linker element followed by the appropriate TGFa sequence. The corresponding downstream PCR reaction utilized a variable 5' mutant oligonucleotide containing the EcoRI linker followed by TGFa sequence, and a universal 3' oligonucleotide containing an arti®cial HindIII recognition sequence followed by promoter sequence.
Ampli®ed DNA was cleaved with KpnI and EcoRI, or EcoRI and HindIII, respectively. Following gel purification, the two digestion products were incubated with KpnI/ HindIII-cleaved pGL2-basic DNA in a triple ligation. Resulting colonies were screened for a restored KpnI/ HindIII TGFa promoter (7564 to +71) containing the desired EcoRI linker replacement. Oligonucleotide primers were: 5'-GCGGAATTCGCTGGCCAGTGCCACCGGCAG-3' LS-6/3':
5'-GCGGAATTCGTCGCCTGCGCCTTTTTCCCCC-3' Subsequent dideoxy sequencing (Sanger et al., 1977) con®rmed the desired mutation as well as the authenticity of surrounding sequence. A consensus AP2 binding site was identi®ed via sequence homology by searching for consensus transcription factor-binding sites using the FindPatterns sequence analysis program and the Transcription Factor Sites data set ®le with 41 mismatch in the software package from Genetics Computer Group (Madison, WI; version 8.0).
Preparation of nuclear extracts
Nuclear extracts were prepared as described (Dignam et al., 1983) with minor modi®cations. Brie¯y, pelleted cells were resuspended in lysis buer [10 mM HEPES (pH 7.9), 1 mM EDTA (pH 8.0), 60 mM KCl, 1 mM DTT, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 0.1% NP-40, 0.4 mM NaF, 0.4 mM Na 3 VO 4 , and 5 mg/ml each aprotinin, pepstatin A, and leupeptin], incubated for 5 min at 408C, and centrifuged at 13 000 g for 5 min at 48C. Pelleted nuclei were resuspended in lysis buer without NP-40 and centrifuged as above. Nuclei were resuspended in extraction buer [0.5 M KCl, 35% glycerol, 100 mM HEPES (pH 7.4), 5 mM MgCl 2 , 0.5 mM EDTA, pH 8.0, 5 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, 1 mM DTT, and 5 mg/ml each aprotinin, pepstatin A, and leupeptin], incubated for 30 min at 48C with occasional mixing, and centrifuged in a TLA100.2 rotor at 55 000 r.p.m. for 45 min at 48C. Clari®ed extracts were aliquoted and stored at 7808C.
DNase I footprinting
A 290 bp Bsu36I-XbaI restriction fragment from the TGFa promoter was initially digested with either Bsu36I (to examine the lower stand) or XbaI (to examine the upper stand), labeled with the Klenow fragment of DNA ploymerase (New England Biolabs) using a mix of 32 P-alabeled dATP, dCTP, dGTP, TTP (New England Nuclear), and then digested with either XbaI or Bsu36I, respectively. Unincorporated deoxynucleotides were removed by Sephadex G-50 chromatography, and the desired probes were puri®ed from non-denaturing 4% acrylamide gels. Puri®ed probes (100 000 c.p.m.) were incubated with 4100 mg of HeLa cell nuclear extract for 30 min at 258C, treated with 0.02 ± 2.0 units of DNase I (Worthington) for 4 min at 258C, digested with proteinase K for 60 min at 508C, extracted with phenol-chloroform, ethanol-precipitated, and resolved on 6% sequencing gels.
To closely examine footprint A, complementary 98 base oligonucleotides encompasing 7221 to 7124 were synthesized and the plus strand oligonucleotide labeled to high speci®c activity using 32 P-g-ATP (New England Nuclear) and T4 polynucleotide kinase (New England Biolabs). After incubating samples for 50 min at 378C, unlabeled deoxynucleotides were added to a ®nal concentration of 0.4 mM, and the samples were further incubated for 5 min at 378C. Reactions were terminated by heating for 15 min at 758C. The NaCl concentration was adjusted to 0.15 M, and a 1.5-fold molar excess of the unlabeled, complementary oligomer was added. Samples were then boiled for 5 min, allowed to cool slowly to room temperature, and the labeled probe puri®ed by Sephadex G-50 chromatography. For binding analysis, puri®ed AP2 protein (20 ± 30 ng) or GP6 extract (20 mg) was preincubated with binding buer [25 mM HEPES (pH 7.9), 50 mM KCl, 1 mM MgCl 2 , 8.5% glycerol, 1 mM EDTA (pH 8.0)] for 5 min at 48C, and 32 P-labeled 98 bp Fp-A probe was added. Samples were incubated for 15 min at 48C, then 5 min at 258C. An equal volume of DNase I buer [20 mM Tris-Cl (pH 7.6), 50 mM NaCl, 1 mM DTT, 100 mg/ml bovine serum albumin (BSA), 20% glycerol, 1 mM MgCl 2 , 2 mM CaCl 2 ] containing 0.005 ± 2.0 units of DNase I (Worthington) was added, and the sample was incubated for 60 s at 258C. Following the addition of proteinase K buer [100 ml: 20 mM Tris-Cl (pH 8.0), 20 mM EDTA (pH 8.0), 0.8% SDS, 100 mg/ml tRNA, 200 mg/ml proteinase K], the reaction was incubated for 30 min at 508C, extracted with phenol/chloroform/isoamyl alcohol (25 : 24 : 1) and ethanol precipitated. The reaction products were dissolved in formamide dye [95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF], boiled for 5 min, and resolved on a 12% sequencing gel parallel to dideoxy sequencing ladders derived from using 5'-TCGCCTAAGG-CAGAGAGGT-3' as a primer on pTGFaLUC template DNA.
Electrophoretic mobility shift assay
For AP2 EMSAs, an Fp-A oligonucleotide (5'-CTC-TTTCCCGTTTCCGCCGCGGGCAGCGCGCT-3') and an hMtIIa AP2 consensus binding sequence (5'-GATC-GAACTGACCGCCCGCGGCCCGT-3') were end-labeled as described above, hybridized to a 1.5-fold molar excess of their unlabeled complement, and separated from free nucleotides by Sephadex G-50 chromatography.
The following oligonucleotides were hybridized to 1.5 molar excess of their respective complementary oligonucleotide and utilized as unlabeled competitor DNAs:
E2F:
5'-ATTTAAGTTTCGCGCCCTTTCTCAA-3' SP1:
5'-ATTCGATCGGGGCGGGGCGAGC-3' AP1:
5'-CGCTTGATGACTCAGCCGGAA-3' MtAP2:
5'-GATCGAACTGACCGCTTGCGGCCCGT-3' MtFp-A-1 (Mt-1):
5'-ACACGCAACGTTTCCGCCGCGGGCAGCGCGCTG-3' MtFp-A-2 (Mt-2):
5'-CTCTTTCCATAGCATACCGCGGGCAGCGCGCTG-3' MtFp-A-3 (Mt-3):
5'-CTCTTTCCCGTTTCCGAACATCAAAGCGCGCTG-3' MtFp-A-4 (Mt-4):
5'-CTCTTTCCCGTTTCCGCCGCGGGCCTACATACT-3'
For EMSA reactions, GP6 extract or anity-puri®ed AP2 protein (Promega; 0.5 footprint units/ml; 10 ng/ml) were preincubated in AP2 binding buer (50 mM KCl, 20 mM HEPES (pH 7.4), 1 mM MgCl 2 , 8.5 glycerol, 1 mM EDTA, 0.5 mg sheared-denatured salmon sperm DNA) for 10 min at 48C, and radiolabeled probe was then added. Reactions were incubated sequentially for 20 min at 48C and 10 min at 258C, and the resulting products then size-separated by electrophoresis through 4% non-denaturing polyacrylamide gels containing 0.256 TBE at 48C with 0.256 TBE as the running buer. An oligonucleotide corresponding to footprint B (5'-TGCGCCTTTTTCCCCCGCGCACA-3') was end-labeled and hybridized to its unlabeled complement as described above. The adenovirus major late promoter TATA box (5'-GGGCTATAAAAGGC-3') was used as an unlabeled competitor DNA. EMSAs using these probes were performed as previously described (Fenton et al., 1996) . Human anti-TFIID rabbit polyclonal antibody was obtained from Santa Cruz Biotechnology.
